Global Parkinson Disease Drug Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 156300
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 133
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Parkinson Disease Drug will have significant change from previous year. By the most conservative estimates of global Parkinson Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Parkinson Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson Disease Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Merck

Akorn

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

H.Lundbeck

Valeant

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Bausch Health

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson Disease Drug Market Size 2016-2026

2.1.2 Parkinson Disease Drug Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Parkinson Disease Drug Segment by Type

2.2.1 Sinemet-CR

2.2.2 Sinemet-CR

2.2.3 Madopar

2.2.4 COMT Inhibitor

2.2.5 Other

2.3 Parkinson Disease Drug Market Size by Type

2.3.1 Global Parkinson Disease Drug Market Size CAGR by Type

2.3.2 Global Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

2.4 Parkinson Disease Drug Segment by Application

2.4.1 Under 40 Years Old

2.4.2 40-65 Years Old

2.4.3 Above 65 Years Old

2.5 Parkinson Disease Drug Market Size by Application

2.5.1 Global Parkinson Disease Drug Market Size CAGR by Application

2.5.2 Global Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

3 Global Parkinson Disease Drug by Players

3.1 Parkinson Disease Drug Market Size Market Share by Players

3.1.1 Global Parkinson Disease Drug Revenue by Players (2019-2021E)

3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2019-2021E)

3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Parkinson Disease Drug by Regions

4.1 Parkinson Disease Drug Market Size by Regions (2016-2021)

4.2 Americas Parkinson Disease Drug Market Size Growth (2016-2021)

4.3 APAC Parkinson Disease Drug Market Size Growth (2016-2021)

4.4 Europe Parkinson Disease Drug Market Size Growth (2016-2021)

4.5 Middle East & Africa Parkinson Disease Drug Market Size Growth (2016-2021)

5 Americas

5.1 Americas Parkinson Disease Drug Market Size by Country (2016-2021)

5.2 Americas Parkinson Disease Drug Market Size by Type (2016-2021)

5.3 Americas Parkinson Disease Drug Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parkinson Disease Drug Market Size by Region (2016-2021)

6.2 APAC Parkinson Disease Drug Market Size by Type (2016-2021)

6.3 APAC Parkinson Disease Drug Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Parkinson Disease Drug by Country (2016-2021)

7.2 Europe Parkinson Disease Drug Market Size by Type (2016-2021)

7.3 Europe Parkinson Disease Drug Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parkinson Disease Drug by Region (2016-2021)

8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021)

8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Parkinson Disease Drug Market Forecast

10.1 Global Parkinson Disease Drug Forecast by Regions (2021-2026)

10.1.1 Global Parkinson Disease Drug Forecast by Regions (2021-2026)

10.1.2 Americas Parkinson Disease Drug Forecast

10.1.3 APAC Parkinson Disease Drug Forecast

10.1.4 Europe Parkinson Disease Drug Forecast

10.1.5 Middle East & Africa Parkinson Disease Drug Forecast

10.2 Americas Parkinson Disease Drug Forecast by Countries (2021-2026)

10.2.1 United States Parkinson Disease Drug Market Forecast

10.2.2 Canada Parkinson Disease Drug Market Forecast

10.2.3 Mexico Parkinson Disease Drug Market Forecast

10.2.4 Brazil Parkinson Disease Drug Market Forecast

10.3 APAC Parkinson Disease Drug Forecast by Region (2021-2026)

10.3.1 China Parkinson Disease Drug Market Forecast

10.3.2 Japan Parkinson Disease Drug Market Forecast

10.3.3 Korea Parkinson Disease Drug Market Forecast

10.3.4 Southeast Asia Parkinson Disease Drug Market Forecast

10.3.5 India Parkinson Disease Drug Market Forecast

10.3.6 Australia Parkinson Disease Drug Market Forecast

10.4 Europe Parkinson Disease Drug Forecast by Country (2021-2026)

10.4.1 Germany Parkinson Disease Drug Market Forecast

10.4.2 France Parkinson Disease Drug Market Forecast

10.4.3 UK Parkinson Disease Drug Market Forecast

10.4.4 Italy Parkinson Disease Drug Market Forecast

10.4.5 Russia Parkinson Disease Drug Market Forecast

10.5 Middle East & Africa Parkinson Disease Drug Forecast by Region (2021-2026)

10.5.1 Egypt Parkinson Disease Drug Market Forecast

10.5.2 South Africa Parkinson Disease Drug Market Forecast

10.5.3 Israel Parkinson Disease Drug Market Forecast

10.5.4 Turkey Parkinson Disease Drug Market Forecast

10.5.5 GCC Countries Parkinson Disease Drug Market Forecast

10.6 Global Parkinson Disease Drug Forecast by Type (2021-2026)

10.8 Global Parkinson Disease Drug Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Merck

11.1.1 Merck Company Information

11.1.2 Merck Parkinson Disease Drug Product Offered

11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Merck Main Business Overview

11.1.5 Merck Latest Developments

11.2 Akorn

11.2.1 Akorn Company Information

11.2.2 Akorn Parkinson Disease Drug Product Offered

11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Akorn Main Business Overview

11.2.5 Akorn Latest Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Parkinson Disease Drug Product Offered

11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 GSK Main Business Overview

11.3.5 GSK Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Parkinson Disease Drug Product Offered

11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Information

11.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Offered

11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Boehringer Ingelheim Main Business Overview

11.5.5 Boehringer Ingelheim Latest Developments

11.6 Teva Pharmaceutical

11.6.1 Teva Pharmaceutical Company Information

11.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Offered

11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Teva Pharmaceutical Main Business Overview

11.6.5 Teva Pharmaceutical Latest Developments

11.7 Abbvie

11.7.1 Abbvie Company Information

11.7.2 Abbvie Parkinson Disease Drug Product Offered

11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Abbvie Main Business Overview

11.7.5 Abbvie Latest Developments

11.8 Kyowa Hakko Kirin Pharma

11.8.1 Kyowa Hakko Kirin Pharma Company Information

11.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered

11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview

11.8.5 Kyowa Hakko Kirin Pharma Latest Developments

11.9 Astellas Pharma

11.9.1 Astellas Pharma Company Information

11.9.2 Astellas Pharma Parkinson Disease Drug Product Offered

11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Astellas Pharma Main Business Overview

11.9.5 Astellas Pharma Latest Developments

11.10 Desitin Arzneimittel

11.10.1 Desitin Arzneimittel Company Information

11.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Offered

11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Desitin Arzneimittel Main Business Overview

11.10.5 Desitin Arzneimittel Latest Developments

11. Endo Pharmaceuticals

11.11.1 Endo Pharmaceuticals Company Information

11.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Offered

11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Endo Pharmaceuticals Main Business Overview

11.11.5 Endo Pharmaceuticals Latest Developments

11.12 F.Hoffmann-La Roche

11.12.1 F.Hoffmann-La Roche Company Information

11.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Offered

11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 F.Hoffmann-La Roche Main Business Overview

11.12.5 F.Hoffmann-La Roche Latest Developments

11.13 H.Lundbeck

11.13.1 H.Lundbeck Company Information

11.13.2 H.Lundbeck Parkinson Disease Drug Product Offered

11.13.3 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 H.Lundbeck Main Business Overview

11.13.5 H.Lundbeck Latest Developments

11.14 Valeant

11.14.1 Valeant Company Information

11.14.2 Valeant Parkinson Disease Drug Product Offered

11.14.3 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Valeant Main Business Overview

11.14.5 Valeant Latest Developments

11.15 Apokyn

11.15.1 Apokyn Company Information

11.15.2 Apokyn Parkinson Disease Drug Product Offered

11.15.3 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Apokyn Main Business Overview

11.15.5 Apokyn Latest Developments

11.16 Orion

11.16.1 Orion Company Information

11.16.2 Orion Parkinson Disease Drug Product Offered

11.16.3 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Orion Main Business Overview

11.16.5 Orion Latest Developments

11.17 Stada Arzneimittel

11.17.1 Stada Arzneimittel Company Information

11.17.2 Stada Arzneimittel Parkinson Disease Drug Product Offered

11.17.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Stada Arzneimittel Main Business Overview

11.17.5 Stada Arzneimittel Latest Developments

11.18 US WorldMeds

11.18.1 US WorldMeds Company Information

11.18.2 US WorldMeds Parkinson Disease Drug Product Offered

11.18.3 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 US WorldMeds Main Business Overview

11.18.5 US WorldMeds Latest Developments

11.19 Bausch Health

11.19.1 Bausch Health Company Information

11.19.2 Bausch Health Parkinson Disease Drug Product Offered

11.19.3 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Bausch Health Main Business Overview

11.19.5 Bausch Health Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Parkinson Disease Drug Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Sinemet-CR

Table 3. Major Players of Trastal

Table 4. Major Players of Madopar

Table 5. Major Players of COMT Inhibitor

Table 6. Major Players of Other

Table 7. Parkinson Disease Drug Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 8. Global Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)

Table 9. Global Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

Table 10. Parkinson Disease Drug Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 11. Global Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)

Table 12. Global Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

Table 13. Global Parkinson Disease Drug Revenue by Players (2019-2021E) & ($ Millions)

Table 14. Global Parkinson Disease Drug Revenue Market Share by Players (2019-2021E)

Table 15. Global Parkinson Disease Drug Key Players Head office and Products Offered

Table 16. Parkinson Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Parkinson Disease Drug Market Size by Regions 2016-2021 & ($ Millions)

Table 20. Global Parkinson Disease Drug Market Size Market Share by Regions 2016-2021

Table 21. Americas Parkinson Disease Drug Market Size by Country (2016-2021) & ($ Millions)

Table 22. Americas Parkinson Disease Drug Market Size Market Share by Country (2016-2021)

Table 23. Americas Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)

Table 24. Americas Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

Table 25. Americas Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)

Table 26. Americas Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

Table 27. APAC Parkinson Disease Drug Market Size by Region (2016-2021) & ($ Millions)

Table 28. APAC Parkinson Disease Drug Market Size Market Share by Region (2016-2021)

Table 29. APAC Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)

Table 30. APAC Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

Table 31. APAC Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)

Table 32. APAC Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

Table 33. Europe Parkinson Disease Drug Market Size by Country (2016-2021) & ($ Millions)

Table 34. Europe Parkinson Disease Drug Market Size Market Share by Country (2016-2021)

Table 35. Europe Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)

Table 36. Europe Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

Table 37. Europe Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)

Table 38. Europe Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

Table 39. Middle East & Africa Parkinson Disease Drug Market Size by Region (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region (2016-2021)

Table 41. Middle East & Africa Parkinson Disease Drug Market Size by Type (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

Table 43. Middle East & Africa Parkinson Disease Drug Market Size by Application (2016-2021) & ($ Millions)

Table 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application (2016-2021)

Table 45. Key and Potential Regions of Parkinson Disease Drug

Table 46. Key Application and Potential Industries of Parkinson Disease Drug

Table 47. Key Challenges of Parkinson Disease Drug

Table 48. Key Trends of Parkinson Disease Drug

Table 49. Global Parkinson Disease Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 50. Global Parkinson Disease Drug Market Size Market Share Forecast by Regions

Table 51. Global Parkinson Disease Drug Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 52. Global Parkinson Disease Drug Market Size Market Share Forecast by Type (2021-2026)

Table 53. Global Parkinson Disease Drug Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 54. Global Parkinson Disease Drug Market Size Market Share Forecast by Application (2021-2026)

Table 55. Merck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 56. Merck Parkinson Disease Drug Product Offered

Table 57. Merck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 58. Merck Main Business

Table 59. Merck Latest Developments

Table 60. Akorn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 61. Akorn Parkinson Disease Drug Product Offered

Table 62. Akorn Main Business

Table 63. Akorn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 64. Akorn Latest Developments

Table 65. GSK Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 66. GSK Parkinson Disease Drug Product Offered

Table 67. GSK Main Business

Table 68. GSK Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 69. GSK Latest Developments

Table 70. Novartis Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 71. Novartis Parkinson Disease Drug Product Offered

Table 72. Novartis Main Business

Table 73. Novartis Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 74. Novartis Latest Developments

Table 75. Boehringer Ingelheim Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 76. Boehringer Ingelheim Parkinson Disease Drug Product Offered

Table 77. Boehringer Ingelheim Main Business

Table 78. Boehringer Ingelheim Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 79. Boehringer Ingelheim Latest Developments

Table 80. Teva Pharmaceutical Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 81. Teva Pharmaceutical Parkinson Disease Drug Product Offered

Table 82. Teva Pharmaceutical Main Business

Table 83. Teva Pharmaceutical Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 84. Teva Pharmaceutical Latest Developments

Table 85. Abbvie Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 86. Abbvie Parkinson Disease Drug Product Offered

Table 87. Abbvie Main Business

Table 88. Abbvie Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 89. Abbvie Latest Developments

Table 90. Kyowa Hakko Kirin Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 91. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered

Table 92. Kyowa Hakko Kirin Pharma Main Business

Table 93. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 94. Kyowa Hakko Kirin Pharma Latest Developments

Table 95. Astellas Pharma Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 96. Astellas Pharma Parkinson Disease Drug Product Offered

Table 97. Astellas Pharma Main Business

Table 98. Astellas Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 99. Astellas Pharma Latest Developments

Table 100. Desitin Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 101. Desitin Arzneimittel Parkinson Disease Drug Product Offered

Table 102. Desitin Arzneimittel Main Business

Table 103. Desitin Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 104. Desitin Arzneimittel Latest Developments

Table 105. Endo Pharmaceuticals Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 106. Endo Pharmaceuticals Parkinson Disease Drug Product Offered

Table 107. Endo Pharmaceuticals Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 108. Endo Pharmaceuticals Main Business

Table 109. Endo Pharmaceuticals Latest Developments

Table 110. F.Hoffmann-La Roche Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 111. F.Hoffmann-La Roche Parkinson Disease Drug Product Offered

Table 112. F.Hoffmann-La Roche Main Business

Table 113. F.Hoffmann-La Roche Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 114. F.Hoffmann-La Roche Latest Developments

Table 115. H.Lundbeck Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 116. H.Lundbeck Parkinson Disease Drug Product Offered

Table 117. H.Lundbeck Main Business

Table 118. H.Lundbeck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 119. H.Lundbeck Latest Developments

Table 120. Valeant Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 121. Valeant Parkinson Disease Drug Product Offered

Table 122. Valeant Main Business

Table 123. Valeant Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 124. Valeant Latest Developments

Table 125. Apokyn Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 126. Apokyn Parkinson Disease Drug Product Offered

Table 127. Apokyn Main Business

Table 128. Apokyn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 129. Apokyn Latest Developments

Table 130. Orion Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 131. Orion Parkinson Disease Drug Product Offered

Table 132. Orion Main Business

Table 133. Orion Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 134. Orion Latest Developments

Table 135. Stada Arzneimittel Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 136. Stada Arzneimittel Parkinson Disease Drug Product Offered

Table 137. Stada Arzneimittel Main Business

Table 138. Stada Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 139. Stada Arzneimittel Latest Developments

Table 140. US WorldMeds Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 141. US WorldMeds Parkinson Disease Drug Product Offered

Table 142. US WorldMeds Main Business

Table 143. US WorldMeds Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 144. US WorldMeds Latest Developments

Table 145. Bausch Health Details, Company Type, Parkinson Disease Drug Area Served and Its Competitors

Table 146. Bausch Health Parkinson Disease Drug Product Offered

Table 147. Bausch Health Main Business

Table 148. Bausch Health Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 149. Bausch Health Latest Developments

List of Figures

Figure 1. Parkinson Disease Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Parkinson Disease Drug Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Parkinson Disease Drug Market Size Market Share by Type (2016-2021)

Figure 7. Parkinson Disease Drug in Under 40 Years Old

Figure 8. Global Parkinson Disease Drug Market: Under 40 Years Old (2016-2021) & ($ Millions)

Figure 9. Parkinson Disease Drug in 40-65 Years Old

Figure 10. Global Parkinson Disease Drug Market: 40-65 Years Old (2016-2021) & ($ Millions)

Figure 11. Parkinson Disease Drug in Above 65 Years Old

Figure 12. Global Parkinson Disease Drug Market: Above 65 Years Old (2016-2021) & ($ Millions)

Figure 13. Global Parkinson Disease Drug Market Size Market Share by Application in 2020

Figure 14. Global Parkinson Disease Drug Revenue Market Share by Player in 2020

Figure 15. Global Parkinson Disease Drug Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Parkinson Disease Drug Market Size 2016-2021 ($ Millions)

Figure 17. APAC Parkinson Disease Drug Market Size 2016-2021 ($ Millions)

Figure 18. Europe Parkinson Disease Drug Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Parkinson Disease Drug Market Size 2016-2021 ($ Millions)

Figure 20. Americas Parkinson Disease Drug Market Size Market Share by Country in 2020

Figure 21. Americas Parkinson Disease Drug Market Size Market Share by Type in 2020

Figure 22. Americas Parkinson Disease Drug Market Size Market Share by Application in 2020

Figure 23. United States Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Parkinson Disease Drug Market Size Market Share by Regions in 2020

Figure 27. APAC Parkinson Disease Drug Market Size Market Share by Type in 2020

Figure 28. APAC Parkinson Disease Drug Market Size Market Share by Application in 2020

Figure 29. China Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Parkinson Disease Drug Market Size Market Share by Countries in 2020

Figure 36. Europe Parkinson Disease Drug Market Size Market Share by Type in 2020

Figure 37. Europe Parkinson Disease Drug Market Size Market Share by Application in 2020

Figure 38. Germany Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application in 2020

Figure 46. Egypt Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Countries Parkinson Disease Drug Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 52. APAC Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 53. Europe Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 55. United States Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 56. Canada Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 59. China Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 60. Japan Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 61. Korea Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 63. India Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 64. Australia Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 65. Germany Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 66. France Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 67. UK Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 68. Italy Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 69. Russia Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 70. Spain Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 73. Israel Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Parkinson Disease Drug Market Size 2021-2026 ($ Millions)

Figure 75. GCC Countries Parkinson Disease Drug Market Size 2021-2026 ($ Millions)